| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-12 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |